The possible link with rare cases of thrombosis has forced the suspension of the COVID-19 vaccination with AstraZeneca in Spain to those under 60 years of age, which moves to a scenario of uncertainty to many people who expected to receive the second dose in the next few weeks.
Although a decision has not been made on the strategy to be followed from now on, the possibility of combining different vaccines, that is, to put a second dose of vaccine different from the vaccine of the first dose.